Yüklüyor......
A novel allosteric inhibitor that prevents IKKβ activation
I kappa B kinase β (IKKβ) is one of the primary targets to regulate canonical NF-κB activity. The misregulation of NF-κB is associated with various diseases, including chronic inflammation and cancers. Most of the known IKKβ inhibitors target its active form and suffer from poor selectivity. In the...
Kaydedildi:
| Yayımlandı: | Medchemcomm |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Royal Society of Chemistry
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6083782/ https://ncbi.nlm.nih.gov/pubmed/30108917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c7md00599g |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|